Kiniksa Pharmaceuticals International Plc (KNSA)
43.24
+0.48
(+1.12%)
USD |
NASDAQ |
Feb 26, 13:53
Kiniksa Pharmaceuticals International Research and Development Expense (Quarterly) : 34.49M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | 2.346M |
| NovoCure Ltd. | 54.03M |
| LivaNova Plc | 51.30M |
| ADMA Biologics, Inc. | 1.528M |
| Alterola Biotech, Inc. | -- |